Amino Acids

, Volume 39, Issue 1, pp 297–304 | Cite as

Thermodynamics of binding of regulatory ligands to tissue transglutaminase

  • Carlo M. Bergamini
  • Alessia Dondi
  • Vincenzo Lanzara
  • Monica Squerzanti
  • Carlo Cervellati
  • Katy Montin
  • Carlo Mischiati
  • Gianluca Tasco
  • Russel Collighan
  • Martin Griffin
  • Rita Casadio
Original Article

Abstract

The transamidating activity of tissue transglutaminase is regulated by the ligands calcium and GTP, via conformational changes which facilitate or interfere with interaction with the peptidyl-glutamine substrate. We have analysed binding of these ligands by calorimetric and computational approaches. In the case of GTP we have detected a single high affinity site (K D ≈ 1 μM), with moderate thermal effects suggestive that binding GTP involves replacement of GDP, normally bound to the protein. On line with this possibility no significant binding was observed during titration with GDP and computational studies support this view. Titration with calcium at a high cation molar excess yielded a complex binding isotherm with a number of “apparent binding sites” in large excess over those detectable by equilibrium dialysis (6 sites). This binding pattern is ascribed to occurrence of additional thermal contributions, beyond those of binding, due to the occurrence of conformational changes and to catalysis itself (with protein self-crosslinking). In contrast only one site for binding calcium with high affinity (K D ≈ 0.15 μM) is observed with samples of enzyme inactivated by alkylation at the active site (to prevent enzyme crosslinkage and thermal effects of catalysis). These results indicate an intrinsic ability of tissue transglutaminase to bind calcium with high affinity and the necessity of careful reassessment of the enzyme regulatory pattern in relation to the concentrations of ligands in living cells, taking also in account effects of ligands on protein subcellular compartimentation.

Keywords

Transglutaminase Binding of ligands Calcium GTP Isothermal titration calorimetry 

Notes

Acknowledgments

This research was supported by grants from University of Ferrara, from Banca Popolare Emilia Romagna and from Fondazione Cassa di Risparmio di Cento to CMB. Authors express their gratitude to Prof. Franco Dallocchio for help in deconvolution of calorimetric data.

References

  1. Ahvazi B, Kim HC, Kee SH, Nemes Z, Steinert PM (2002) Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation. EMBO J 21:2055–2067CrossRefPubMedGoogle Scholar
  2. Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, Lorand L, Iismaa SE, Graham RM (2006a) Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc Natl Acad Sci USA 103:19683–19688CrossRefPubMedGoogle Scholar
  3. Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE (2006b) Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J Biol Chem 281:12603–12609CrossRefPubMedGoogle Scholar
  4. Bergamini CM (1988) GTP modulates calcium binding and cation-induced conformational changes in erythrocyte transglutaminase. FEBS Lett 239:255–258CrossRefPubMedGoogle Scholar
  5. Bergamini CM (2007) Effects of ligands on the stability of tissue transglutaminase: studies in vitro suggest possible modulation by ligands of protein turn-over in vivo. Amino Acids 33:415–421CrossRefPubMedGoogle Scholar
  6. Bergamini CM, Signorini M (1992) Purification of testicular transglutaminase by hydrophobic chromatography on phenyl-sepharose. Biochem Int 27:557–565PubMedGoogle Scholar
  7. Bergamini CM, Signorini M (1993) Studies on tissue transglutaminases: interaction of erythrocyte type-2 transglutaminase with GTP. Biochem J 291:37–39PubMedGoogle Scholar
  8. Bergamini CM, Griffin M, Pansini FS (2005) Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions. Curr Med Chem 12:2357–2372CrossRefPubMedGoogle Scholar
  9. Candi E, Paradisi A, Terrinoni A, Pietroni V, Oddi S, Cadot B, Jogini V, Meiyappan M, Clardy J, Finazzi-Agro A, Melino G (2004) Transglutaminase 5 is regulated by guanine–adenine nucleotides. Biochem J 381:313–319CrossRefPubMedGoogle Scholar
  10. Casadio R, Polverini E, Mariani P, Spinozzi F, Carsughi F, Fontana A, Polverino de Laureto P, Matteucci G, Bergamini CM (1999) The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem 262:672–679CrossRefPubMedGoogle Scholar
  11. Chatziantoniou C, Dussaule JC (2005) Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289:F227–F234CrossRefPubMedGoogle Scholar
  12. Fesus L, Szondy Z (2005) Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579:3297–3302CrossRefPubMedGoogle Scholar
  13. Freund KF, Doshi KP, Gaul SL, Claremon DA, Remy DC, Baldwin JJ, Pitzenberger SM, Stern AM (1994) Transglutaminase inhibition by 2-[(2-oxopropyl)thio]-imidazolium derivatives: mechanism of factor XIIIa inactivation. Biochemistry 33:10109–10119CrossRefPubMedGoogle Scholar
  14. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396CrossRefPubMedGoogle Scholar
  15. Iismaa SE, Wu MJ, Nanda N, Church WB, Graham RM (2000) GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem 275:18259–18365CrossRefPubMedGoogle Scholar
  16. Iismaa SE, Holman S, Wouters MA, Lorand L, Graham RM, Husain A (2003) Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases. Proc Natl Acad Sci USA 100:12541–12636CrossRefGoogle Scholar
  17. Johnson TS, El-Koraie AF, Skill NJ, Baddour NM, El Nahas AM, Njloma M, Adam AG, Griffin M (2003) Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 14:2052–2062CrossRefPubMedGoogle Scholar
  18. Johnson TS, Fisher M, Haylor JL, Hau Z, Skill NJ, Jones R, Saint R, Coutts I, Vickers ME, El Nahas AM, Griffin M (2007) Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol 18:3078–3088CrossRefPubMedGoogle Scholar
  19. Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM (2005) Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol 19:373–387CrossRefPubMedGoogle Scholar
  20. Lai TS, Bielawska A, Peoples KA, Hannun YA, Greenberg CS (1997) Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J Biol Chem 272:16295–16300CrossRefPubMedGoogle Scholar
  21. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, Greenberg CS (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40:4904–4910CrossRefPubMedGoogle Scholar
  22. Lai TS, Liu Y, Tucker T, Daniel KR, Sane DC, Toone E, Burke JR, Strittmatter WJ, Greenberg CS (2008) Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol 15:969–978CrossRefPubMedGoogle Scholar
  23. Liu S, Cerione RA, Clardy J (2002) Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99:2743–2747CrossRefPubMedGoogle Scholar
  24. Mangala LS, Mehta K (2005) Tissue transglutaminase (TG2) in cancer biology. Prog Exp Tumor Res 38:125–138CrossRefPubMedGoogle Scholar
  25. Mariani P, Carsughi F, Spinozzi F, Romanzetti S, Meier G, Casadio R, Bergamini CM (2000) Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data. Biophys J 78:3240–3251CrossRefPubMedGoogle Scholar
  26. Mian S, el Alaoui S, Lawry J, Gentile V, Davies PJ, Griffin M (1995) The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett 370:27–31CrossRefPubMedGoogle Scholar
  27. Milakovic T, Tucholski J, McCoy E, Johnson GV (2004) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 279:8715–8722CrossRefPubMedGoogle Scholar
  28. Mitkevich OV, Shainoff JR, DiBello PM, Yee VC, Teller DC, Smejkal GB, Bishop PD, Kolotushkina IS, Fickenscher K, Samokhin GP (1998) Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody. J Biol Chem 273:14387–14391CrossRefPubMedGoogle Scholar
  29. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated Docking using a Lamarckian Genetic Algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662CrossRefGoogle Scholar
  30. Murthy SN, Lorand L (2000) Nucleotide binding by the erythrocyte transglutaminase/Gh protein, probed with fluorescent analogs of GTP and GDP. Proc Natl Acad Sci USA 97:7744–7747CrossRefPubMedGoogle Scholar
  31. Park H, Park ES, Lee HS, Yun HY, Kwon NS, Baek KJ (2001) Distinct characteristic of Gα (h) (transglutaminase II) by compartment: GTPase and transglutaminase activities. Biochem Biophys Res Comm 284:496–500CrossRefPubMedGoogle Scholar
  32. Pinkas DM, Strop P, Brunger AT, Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5:e327CrossRefPubMedGoogle Scholar
  33. Siegel M, Khosla C (2007) Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther 115:232–245CrossRefPubMedGoogle Scholar
  34. Smethurst PA, Griffin M (1996) Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J 313:803–808PubMedGoogle Scholar
  35. Sohn J, Kim TI, Yoon YH, Kim JY, Kim SY (2003) Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest 111:121–128PubMedGoogle Scholar
  36. Velazquez Campoy A, Freire E (2005) ITC in the post-genomic era ? Priceless. Biophys Chem 115:115–124CrossRefPubMedGoogle Scholar
  37. Zhang J, Lesort M, Guttmann RP, Johnson GV (1998) Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J Biol Chem 273:2288–2295CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Carlo M. Bergamini
    • 1
    • 2
  • Alessia Dondi
    • 1
  • Vincenzo Lanzara
    • 1
  • Monica Squerzanti
    • 1
  • Carlo Cervellati
    • 1
  • Katy Montin
    • 1
  • Carlo Mischiati
    • 1
  • Gianluca Tasco
    • 3
  • Russel Collighan
    • 4
  • Martin Griffin
    • 4
  • Rita Casadio
    • 3
  1. 1.Department of Biochemistry and Molecular BiologyUniversity of FerraraFerraraItaly
  2. 2.Interdisciplinary Centre for the Study of Inflammation (ICSI)University of FerraraFerraraItaly
  3. 3.Department of Biology, Biocomputing CentreUniversity of BolognaBolognaItaly
  4. 4.School of Life and Health SciencesAston UniversityBirminghamUK

Personalised recommendations